Overview

Cannabinoids for Pain Control During Medical Abortion

Status:
Completed
Trial end date:
2019-05-28
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine if a synthetic cannabis derivative, dronabinol, in addition to ibuprofen, decreases maximum pain scores compared to ibuprofen and placebo in women undergoing medical abortion. Results of this study will help providers counsel patients regarding cannabis use during medical abortion.
Phase:
Phase 4
Details
Lead Sponsor:
Oregon Health and Science University
Collaborator:
Society of Family Planning
Treatments:
Dronabinol